Treatment with oral antibiotics of febrile neutropenia in onco-haematology: The experience of the EORTC anti-microbial group;Traitement antibiotique oral des neutropénies fébriles en onco-hématologie: L'expérience du groupe antimicrobien de l'EORTC

Presse Medicale

Volumn 33, Issue 5, 2004, Pages 327-329

  Cometta, Alain ^a   Kern, W ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN;

ANTIBIOTIC THERAPY; DIARRHEA; DRUG EFFICACY; FEBRILE NEUTROPENIA; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; NEPHROTOXICITY; PATIENT SELECTION; REVIEW; TREATMENT OUTCOME;

EID: 1542720575     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98578-8     Document Type: Review

References (7)

1. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992; 10: 316-22.
2. Malik IA, Khan WA, Karim M, Aziz Z, Khan A. Feasability of outpatient management of fever in cancer patients with low-risk neutropenia. Am J Med 1995; 98: 224-31.
3. Rubenstein EB, Rolston V, Benjamin RS, et al. Outpatient treatment of febrile episodes on low-risk neutropenic patients with cancer. Cancer 1993; 71: 3640-6.
4. Kern WV, Cometta A, DeBock R, Langenaeken J, Paesmans M, Gaya H for the International antimicrobial therapy cooperative group of the EORTC. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999; 341: 312-18.
5. The EORTC antimicrobial therapy cooperative group. Efficacy and toxicity of single daily dose of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infections in patients with cancer and granulocytopenia. Ann Intern Med 1993; 119: 584-93.
6. Freifeld A, Marchigiani D, Walsh T et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999; 341: 305-11.
7. Klastersky J, Paesmans M, Rubenstein EB et al. for the Study section on infections of the multinational association for supportive care in cancer. J Clin Onco 2000; 18: 3038-51.